Troinex, Switzerland

Eric Allémann

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bracco Suisse Sa. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eric Allémann

Introduction

Eric Allémann is a notable inventor based in Troinex, Switzerland. He has made significant contributions to the field of medical technology, particularly in the development of gas-filled microvesicles. His work focuses on creating formulations that enhance therapeutic applications using ultrasound technology.

Latest Patents

Eric Allémann holds a patent for a lipid formulation designed for preparing stable gas-filled microvesicles. This formulation includes distearoyl-phosphatidylcholine (DSPC), dipalmitoylphosphatidylethanolamine-PEG5000 (DPPE-PEG5000), and palmitic acid in a specific relative molar ratio. The innovative formulation is particularly useful for therapeutic applications involving ultrasounds.

Career Highlights

Throughout his career, Eric has been associated with Bracco Suisse SA, a company known for its advancements in medical imaging and related technologies. His work has contributed to the development of new therapeutic methods that leverage ultrasound technology for improved patient outcomes.

Collaborations

Eric has collaborated with notable colleagues such as Philippe Bussat and Samir Cherkaoui. These partnerships have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Eric Allémann's contributions to the field of medical technology through his innovative patent on gas-filled microvesicles highlight his role as a significant inventor. His work continues to influence therapeutic applications and improve medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…